PHENYLEPHRINE CIPLA, PHENYLIP, VASOPHEN (Cipla Australia Pty Ltd)
Product name
PHENYLEPHRINE CIPLA, PHENYLIP, VASOPHEN
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
253 working days (255)
Active ingredients
phenylephrine hydrochloride
Registration type
New generic medicine
Indication
PHENYLEPHRINE CIPLA, PHENYLIP, VASOPHEN (solution for injection) are intended for the maintenance of an adequate level of blood pressure during spinal and inhalation anaesthesia and for the treatment of vascular failure in shock, shock-like states, and drug-induced hypotension, or hypersensitivity. It is also employed to overcome paroxysmal supraventricular tachycardia, to prolong spinal anaesthesia, and as a vasoconstrictor in regional analgesia.